Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.47 USD | +1.50% | +3.61% | +32.45% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.45% | 2.32B | |
+12.51% | 3,096B | |
+12.68% | 85.37B | |
+7.61% | 77.1B | |
-13.71% | 54.31B | |
-22.56% | 47.92B | |
+26.21% | 47.74B | |
+25.42% | 42.15B | |
+69.48% | 38.06B | |
-8.00% | 24.73B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cowen Adjusts Price Target on Cellebrite DI to $10 From $13, Keeps Outperform Rating